Study Stopped
difficulty in recruitment. lack of sponsorship
Combined Hormonal Versus Progestin Only Contraception During Lactation
1 other identifier
observational
N/A
0 countries
N/A
Brief Summary
Objective: To determine and compare the effect of low dose estrogen combined hormonal contraceptives and progestin-only contraceptives on lactation. The subjects will be drawn from a healthy obstetric population in each center, where possible preliminary contact during antenatal period. At the postpartum visit, subjects that express their wish for a hormonal contraceptive method will be offered enrollment. After obtaining an informed consent the participants will be allocated according to their free wish to either receive a combined preparation containing 0.02 mg ethylestradiol and 0.15 mg desogestrel (Mercilon, Organon) or a progestin only pill containing 0.075 mg desogestrel (Cerazette, Organon). Demographic, habits and perinatal data will be collected and stored to analysis. Frequency and methods of observation: All women will be followed at 6 (baseline), 9 and 12 weeks post - partum. Instruction will be given as to recording information on intercurrent disease, frequency of nursing and use of complementary formula supplements. Maternal BMI calculation ( weight/height2) will be obtained at first visit. The objective is to compare the capacity of the breast to secrete milk under standard conditions and evaluate the influence of different hormonal contraception means. Thus samples will be collected at 6 weeks (enrollment) and the 9 and 12 weeks visits. An Egnell pump will be used for a maximum of 20 minutes form from both breasts, simulating a regular breast feeding. A total of 10 ml aliquot will be taken for composition analysis and the rest will be offered to the infant. The milk volume/feeding will be estimated and expressed in ml/feeding and multiplied by the number of feedings reported. Outcome variables: Milk volume, infant growth at each visit and biochemical markers of milk analysis : lipid, casein and carbohydrate content
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jun 2006
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2006
CompletedFirst Submitted
Initial submission to the registry
September 11, 2006
CompletedFirst Posted
Study publicly available on registry
September 12, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2007
CompletedMay 16, 2017
April 1, 2017
7 months
September 11, 2006
May 14, 2017
Conditions
Study Arms (2)
combined contraceptives
combined contraceptives
pregesterone only contraceptives
pregesterone only contraceptives
Eligibility Criteria
You may qualify if:
- healthy
You may not qualify if:
- mothers to infants that their weight will be below the 10th percentile
- mothers to infants sensitive to milk
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shaare Zedek Medical Centerlead
- Organoncollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Naama Srebnik, MD
A resident at the Shaare Zedek Medical Center
- STUDY DIRECTOR
Surina Grisaru-Granovsky
A senior doctor at the Shaare Zedek Medical Center
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 11, 2006
First Posted
September 12, 2006
Study Start
June 1, 2006
Primary Completion
January 1, 2007
Study Completion
January 1, 2007
Last Updated
May 16, 2017
Record last verified: 2017-04